Literature DB >> 1103569

The basement membrane of the uterine cervix in dysplasia and squamous carcinoma: an immunofluorescent study with antibodies to basement membrane antigen.

C A Rubio, P Biberfeld.   

Abstract

Histological preparations with normal epithelium, dysplasia, carcinoma in situ and squamous invasive carcinoma of human cervix were studied by immunofluorescence using human sera containing antibodies against basement membrane material, against intercellular substance of squamous epithelium (ISSE) and against reticulin. A continuous basement membrane was observed in normal epithelium dysplasia and carcinoma in situ, but was faintly stained, discontinuous or even absent in specimens with invasive squamous carcinoma. Staining with anti-reticulin did not reveal any condensation in the basement membrane areas in any of the preparations examined. ISSE was demonstrated in the normal epithelium, dysplasia and carcinoma in situ as well as in invasive carcinoma.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1103569     DOI: 10.1111/j.1699-0463.1975.tb01408.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


  5 in total

1.  Tumor dedifferentiation: an important step in tumor invasion.

Authors:  H Gabbert; R Wagner; R Moll; C D Gerharz
Journal:  Clin Exp Metastasis       Date:  1985 Oct-Dec       Impact factor: 5.150

2.  Collagenase--a marker enzyme in human bladder cancer?

Authors:  G Wirl; J Frick
Journal:  Urol Res       Date:  1979-06-22

Review 3.  Mechanisms of tumor invasion: evidence from in vivo observations.

Authors:  H Gabbert
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

4.  The basement membrane in experimentally induced atypias and carcinoma of the uterine cervix in mice. An immunofluorescence study.

Authors:  C A Rubio; P Biberfeld
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-02-09

Review 5.  Extracellular matrix destruction by invasive tumor cells.

Authors:  P A Jones; Y A De Clerck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.